Info
A. Definition
- Depression developing during autumn or winter
- Depression remitting in spring or summer
- This cycle occurs for at least 2 successive years
- "Summer" SAD also described, but very uncommon
- ICD-10 Research Diagnostic Criteria
- Three or more episodes of affective disorder for 3 or more consecutive years
- Onsets and remissions within a particular 90-day period of the year
- Seasonal episodes substantially outnumber non-seasonal episodes
- SAD is a form of bipolar affective or recurrent depressive disorder
- SAD with minor depression is more common amongst women
- SAD with major depression is more common amongst men
- Uncommon in children and elderly
- Lifetime prevalance of SAD is probably ~1%
B. Pathogenesis
- Unclear etiology
- Reduced daylight period likely contributes
- Bright light treatment may improve symptoms
- However, unclear that reduced light itself is the problem
- Decreased availability of dopamine in ocular neurons has been found
- Impaired transmission of neuropeptide Y and serotonin to circadian pacemaker implicated
- Disturbed serotonergic activity implicated in winter SAD
- Unclear if specific serotonin receptor subsystems are responsible
- Some data suggest increased risk of SAD with specific serotonin transporter mutations
- Reduced norepinephrine, cortisol, and growth hormone responses to serotonin agents
- Melatonin production and function appears to be normal in SAD
C. Symptoms and Signs
- Social withdrawal, decreased activity, sadness, anxiety
- Decreased libido, poor sleep quality, irritability, carbohydrate craving, weight increase
- Suicidal thoughts are uncommon
- Decreased weight is infrequent
D. Treatment
- Similar to other forms of depressive and affective disorder
- However, bright-light treatment is recommended first line treatment for winter SAD
- Best treatments use 2500 lux artificial light for 2 hours in morning
- Higher intensities for shorter exposures (10,000 lux for 30 minutes) equally effective
- Light response ~80%
- Antidepressants are effective in SAD
- Sertraline (Zoloft®)
- Fluoxetine (Prozac®)
- Moclobemide, an MAO inhibitor, was not effective
- Bright light treatment may be combined with antidepressants
References
- Partonen T and Lonnqvist J. 1998. Lancet. 352(9317):1369